| Pinpointing the tumor-specific T cells via TCR clusters MM Goncharov, EA Bryushkova, NI Sharaev, VD Skatova, ... Elife 11, e77274, 2022 | 16 | 2022 |
| Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study EA Bryushkova, VD Skatova, ZY Mutovina, AI Zagrebneva, DS Fomina, ... PloS one 17 (8), e0273340, 2022 | 13 | 2022 |
| Deciphering repertoire of B16 melanoma reactive TCRs by immunization, in vitro restimulation and sequencing of IFNγ-secreting T cells AV Izosimova, DV Yuzhakova, VD Skatova, LN Volchkova, EV Zagainova, ... International Journal of Molecular Sciences 22 (18), 9859, 2021 | 5 | 2021 |
| Ultrasensitive allele inference from immune repertoire sequencing data with MiXCR A Mikelov, G Nefediev, A Tashkeev, OL Rodriguez, DA Ortmans, ... bioRxiv, 2023.10. 10.561703, 2023 | 1 | 2023 |
| Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: a retrospective cohort study EA Bryushkova, VD Skatova, ZY Mutovina, AI Zagrebneva, DS Fomina, ... medRxiv, 2022.03. 31.22269942, 2022 | | 2022 |
| 7MO Effect of anti-CTLA-4 immunotherapy on lymphocyte subset and activation profiles and clonal composition on the B16F0 mouse melanoma model DV Yuzhakova, AV Izosimova, GV Sharonov, LN Volchkova, IA Shagina, ... Annals of Oncology 32, S362-S363, 2021 | | 2021 |
